The aforementioned transaction, reported via the customary SEC filing, represents a modest 1.49% addition to the fund’s $523.16 million in reportable AUM as of December 31st. A figure, one notes, that scarcely registers in the grand scheme of things, yet provides a pleasant talking point for those of us who monitor such ephemera.
The transaction, recorded on January 23rd, involved the acquisition of 42,862 shares of the ACWX fund. It wasn’t a tempest, not a dramatic shift in the portfolio’s foundations, but rather a deliberate layering, a thickening of the protective membrane around the firm’s considerable holdings. The fund itself, a vessel carrying the hopes and anxieties of global markets, experienced a corresponding swell, its value increasing by $3.27 million – a figure composed of both the initial investment and the capricious favor of the market. One could almost feel the weight of those billions shifting, settling, as if the fund were a great, slumbering beast roused from its sleep.
The filing with the Securities and Exchange Commission reveals a deliberate reduction, a pruning of the holding during the final quarter. The estimated value of the relinquished shares amounts to $4.67 million, a figure arrived at through the averaging of prices, a practice that obscures the individual agonies and triumphs of each day’s trading. The fund concluded the quarter with a mere 6,326 shares, valued at $1.30 million. The reported quarter-end position value, once a substantial presence, had dwindled by $4.58 million – a consequence not solely of trading, but of the stock’s own restless wandering.
The filing with the Securities and Exchange Commission details the acquisition of 653,537 shares during the final quarter of the past year. A modest addition to the holdings of Kirr Marbach, yet a signal, however faint, of a shift in perspective. This is not a panicked flight to safety, nor a reckless pursuit of yield, but a measured attempt to inoculate a portfolio against the inevitable vicissitudes of the market.
This is not entirely surprising. The prevailing narrative of artificial intelligence, so relentlessly trumpeted, had already priced in Arm’s potential. The company’s strength, of course, lies in its power efficiency – a quality increasingly valued in the data centres that now house this digital leviathan. (Amazon‘s Graviton5, a processor of decidedly unromantic nomenclature, illustrates the point: a 30% improvement in performance coupled with a 30% reduction in cost. A neat trick, if one can overlook the vulgarity of such demonstrable efficiency.)
They bought 226,705 shares of BSCT. That’s a lot of shares. The transaction went down on January 26th, which feels like a lifetime ago in market years. The price was based on the fourth quarter of 2025, which, when you think about it, is practically ancient history. I spent a good ten minutes trying to remember what I had for breakfast that day, and failed miserably. It’s unsettling how quickly things become irrelevant.
The consensus forecast, so readily available to those who traffic in such things, anticipated earnings of $1.81 per share on sales of $1.41 billion. Logitech, with a display of competence that borders on the unsettling, delivered $1.93 per share on sales of $1.42 billion. A rounding error, perhaps, but a positive one. One wonders if the analysts are entirely fulfilling their function.
In a move as subtle as a fireworks display, Coinbase proclaimed the formation of an independent advisory cabal to delve into the quantum mysteries threatening our beloved blockchain. Six titans from the global quantum realm were summoned-yes, the Avengers of cryptography-tasked with evaluating our digital future.
The details, as always, are…dense. A table, naturally. I always think of tables as a passive-aggressive way for companies to say, “We’re providing transparency, but good luck making sense of it.” Apparently, this wasn’t a sudden, panicked sell-off. It was a pre-planned thing, a “Rule 10b5-1 trading plan.” Which sounds suspiciously like a loophole designed to make rich people feel less guilty. The numbers, stripped of all drama, are these: he sold, reducing his direct holdings by 7.23% to 159,126 shares. He still has a decent stash, and about 2,085 shares indirectly. It’s like watching someone slowly, methodically empty a cookie jar. You know they’ll stop eventually, but the process is… unsettling.
Oracle, once synonymous with relational databases—a phrase that now feels deliciously archaic—has discovered a peculiar aptitude for high-performance computing. It’s a niche, certainly, but one that resonates with a certain clientele—those who demand not just processing power, but a certain… finesse. A computational ballet, if you will. And this, naturally, has not gone unnoticed. The recent $300 billion arrangement with OpenAI—a sum that, when uttered, feels suspiciously like a whispered conspiracy—has, predictably, inflated their backlog to a rather imposing $523 billion. A number that, when contemplated, resembles a slowly unfurling scroll of future revenue.